2nd Circ. Rejects 'New Standard' Of Patent Monopolies

By Bryan Koenig · March 18, 2024, 10:09 PM EDT

A Second Circuit panel on Monday revived antitrust allegations accusing Novartis of concealing the true history of an eye syringe treatment's development from the U.S. Patent and Trademark Office to edge...

To view the full article, register now.